SCIDEV LTD — Director's Dealing 2021

Nov 28, 2021

==> picture [225 x 45] intentionally omitted <==

Unit 1 8 Turbo Road Kings Park NSW 2148 Australia ABN 25 001 150 849

Email: projects@scidev.com.au Website: www.scidev.com.au ASX code: SDV

Companies Announcements Office Australian Stock Exchange

29 November 2021

SPP Share Issue, Appendix 2A and 3Y’s

Highlights

SciDev Ltd (ASX: SDV) (‘ SciDev ’ or ‘ the Company ’) has today issued the new shares subject of its recent SPP (Ref ASX: 26 November 2021). An Appendix 2A Notice covering the issue of the 527,671 new shares will follow shortly after this announcement.

Appendix 3Y Notices for Messrs Lewis Utting and Jon Gourlay are attached.

Notice Under Section 708A(5)(e)

The Corporations Act 2001 (the “Act”) restricts the on-sale of securities issued without disclosure unless the sale is exempt under sections 708 or 708A. By the Company giving this notice, a sale of the securities noted above will fall within the exemption in section 708A(5)(e) of the Act.

The Company hereby notifies ASX under paragraph 708A(5)(e) of the Act that:

1. the Company will issue the securities without disclosure to the investor under Part 6D.2 of the Act;

2. as at the date of this notice, the Company has complied with:

3. a. the provisions of Chapter 2M of the Act as they apply to the Company;

4. b. section 674 of the Act; and

except as may be set out in this notice, as at the date of this notice there is no other information that is excluded information which is required to be set out in this notice under Section 708A(6)(e) of the Act.

On behalf of SciDev Ltd

==> picture [107 x 39] intentionally omitted <==

Lewis Utting Managing Director and CEO

Heath Roberts Company Secretary

This release has been approved by the Board of Directors of SciDev Limited.

For Further Information:

Corporate Investors Lewis Utting – MD & CEO Craig Sainsbury – Market Eye Heath Roberts – Company Secretary craig.sainsbury@marketeye.com.au (+61) 2 9622 5185 (+61) 428 550 499

About SciDev

SciDev is a leader in the environmental solutions market focused on water intensive industries. SciDev brings together world-class technology, chemistry and application to solve pressing operational and environmental issues for the water, oil and gas, mining and construction markets.

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity SciDev Ltd ABN 25 001 150 849

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Lewis UTTING
Date of last notice	17112020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Not Applicable
Date of change	29112021
No. of securities held prior to change	929,989 fully paid ordinary shares (Lewis Utting), 4,518,140 fully paid ordinary shares (Lehos and Utting Family Trust) 800,000 options: expiry 23072022, exercise price $0.10.
Class	Refer above
Number acquired	92,306 fully paid ordinary shares

• See chapter 19 for defined terms.

Appendix 3Y Page 1 28/11/2018

Appendix 3Y Change of Director’s Interest Notice

Number disposed	0
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$0.65 per share
No. of securities held after change	976,142 fully paid ordinary shares (Lewis Utting), 4,564,293 fully paid ordinary shares (Lehos and Utting Family Trust) 800,000 options: expiry 23072022, exercise price $0.10.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	SPP

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	NIL/NOT APPLICABLE
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation

• See chapter 19 for defined terms.

Appendix 3Y Page 2

28/11/2018

Appendix 3Y Change of Director’s Interest Notice

Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed NO/NOT APPLICABLE above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 3 28/11/2018

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity SciDev Limited ABN 25 001 150 849

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Jon Gourlay
Date of last notice	09092020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Jon Gourlay
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change	29112021
No. of securities held prior to change	954,628 fully paid ordinary shares
Class	Refer above
Number acquired	92,306 fully paid ordinary shares
Number disposed	0
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$0.65 per share

• See chapter 19 for defined terms.

Appendix 3Y Page 1 28/11/2018

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	1,046,934 fully paid ordinary shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	SPP

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	NIL / NOT APPLICABLE
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

• See chapter 19 for defined terms.

Appendix 3Y Page 2

28/11/2018

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	NO / NOT APPLICABLE
If so, was prior written clearance provided to allow the trade to proceed during this period?	NA
If prior written clearance was provided, on what date was this provided?	NA

• See chapter 19 for defined terms.

Appendix 3Y Page 3 28/11/2018